Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Tumor Immunotherapy01:27

Tumor Immunotherapy

639
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
639
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
Tumor Progression02:07

Tumor Progression

6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disease modelling with in vitro vascularised organoids.

Disease models & mechanisms·2026
Same author

Single-Cell Mitochondrial Lineage Tracing Decodes Fate Decision and Spatial Clonal Architecture in Human Hematopoietic Organoids.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

NX-1607: lifting the Cbl-b brake to promote T cell activation through MAPK/ERK pathways.

Journal for immunotherapy of cancer·2025
Same author

Integrating spatial and single-cell transcriptomics data using deep generative models with SpatialScope.

Nature communications·2023
Same author

PD-L1 regulates inflammatory programs of macrophages from human pluripotent stem cells.

Life science alliance·2023
Same author

Unveiling the immune system aging in single-cell resolution.

Journal of leukocyte biology·2023
Same journal

Hematopoietic Cell Fate Reprogramming in the Context of Pathological Processes and Translational Opportunities.

Cellular reprogramming·2026
Same journal

Liquid-Cell Interactions in the Tumor Microenvironment: Mechanisms, Biomarkers, and Therapeutic Opportunities.

Cellular reprogramming·2026
Same journal

Reprogramming Stars #28: Stem Cell-Based Approaches to Build Blood Vessels and Liver Tissue-An Interview with Dr. Lay Teng Ang.

Cellular reprogramming·2026
Same journal

Isolation of Buffalo (<i>Bubalus bubalis</i>) Theca Cells: A Comparison Among Three Protocols.

Cellular reprogramming·2026
Same journal

The Involvement of Gut Microbiota and Their Key Metabolites in Regulating Fetal Development via the Gut-Placental Axis.

Cellular reprogramming·2026
Same journal

Reprogramming Stars #27: Drawing Inspiration from Reprogramming to Guide Stem Cell Differentiation: An Interview with Dr. Kyle Loh.

Cellular reprogramming·2026
See all related articles

Related Experiment Video

Updated: Aug 23, 2025

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
07:44

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

7.6K

The Tumor Microenvironment Reprograms Immune Cells.

Handi Cao1,2, Sanxing Gao1, Ritika Jogani1

  • 1School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pokfulam, Hong Kong.

Cellular Reprogramming
|October 27, 2022
PubMed
Summary
This summary is machine-generated.

Tumor cells reprogram immune cells within the tumor microenvironment (TME) and systemically, creating an immunosuppressive environment. Understanding these mechanisms is key to improving cancer immunotherapy and developing new treatments.

Keywords:
immune cell reprogrammingmetabolismmicroenvironmenttumor

More Related Videos

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

616
In Vitro Assay to Study Tumor-macrophage Interaction
08:36

In Vitro Assay to Study Tumor-macrophage Interaction

Published on: August 1, 2019

7.6K

Related Experiment Videos

Last Updated: Aug 23, 2025

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
07:44

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

7.6K
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

616
In Vitro Assay to Study Tumor-macrophage Interaction
08:36

In Vitro Assay to Study Tumor-macrophage Interaction

Published on: August 1, 2019

7.6K

Area of Science:

  • Oncology
  • Immunology
  • Cancer Biology

Background:

  • The tumor microenvironment (TME) is a complex ecosystem containing cancer cells and various stromal cells, including immune cells, fibroblasts, endothelial cells, and pericytes.
  • Tumor cells actively manipulate the TME, reprogramming stromal and immune cells to foster an immunosuppressive milieu and metabolic competition, thereby hindering anti-tumor responses.
  • This reprogramming extends beyond the tumor site, impacting immune cells systemically.

Approach:

  • This review synthesizes current knowledge on how tumor cells reprogram immune cells within the TME and in the peripheral blood.
  • Utilizes findings from single-cell sequencing technologies to dissect tumor-specific cellular characteristics and interactions.
  • Focuses on the mechanisms of immune cell reprogramming by tumor cells.

Key Points:

  • Tumor cells induce an immunosuppressive environment by reprogramming immune cells and other stromal components within the TME.
  • Immune cell reprogramming by tumors occurs both locally within the TME and systemically, affecting immune surveillance and response.
  • Single-cell sequencing has provided unprecedented resolution in understanding these cellular interactions and tumor heterogeneity.

Conclusions:

  • Elucidating tumor-induced immune cell reprogramming is crucial for enhancing the efficacy of existing cancer immunotherapies.
  • This knowledge can inspire novel therapeutic strategies and combination treatments to overcome cancer's immune evasion tactics.
  • Further research into these complex interactions promises to advance our ability to combat cancer effectively.